Ten Months On, Abbott, Wockhardt Terminate Deal For Nutritional Business
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Pharmaceuticals-to-diagnostics giant Abbott and debt-ridden Indian drug maker Wockhardt jointly agreed to call off the $130 million deal for a nutritional business that the two had announced barely 10 months ago